COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR
Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials.